SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010156
Filing Date
2019-11-06
Accepted
2019-11-06 16:06:25
Documents
76
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q idra-20190930x10q.htm 10-Q 1809448
2 EX-10.1 idra-20190930ex10109dbe8.htm EX-10.1 403024
3 EX-31.1 idra-20190930ex311e50b0f.htm EX-31.1 18381
4 EX-31.2 idra-20190930ex3122b3d1f.htm EX-31.2 18286
5 EX-32.1 idra-20190930ex32165a079.htm EX-32.1 7948
6 EX-32.2 idra-20190930ex32291f908.htm EX-32.2 7718
7 GRAPHIC idra20190930x10q001.jpg GRAPHIC 14972
8 GRAPHIC idra20190930x10q002.jpg GRAPHIC 7572
9 GRAPHIC idra20190930x10q003.jpg GRAPHIC 8010
10 GRAPHIC idra20190930x10q004.jpg GRAPHIC 7470
11 GRAPHIC idra20190930x10q005.jpg GRAPHIC 9393
  Complete submission text file 0001558370-19-010156.txt   6924074

Data Files

Seq Description Document Type Size
12 EX-101.INS idra-20190930.xml EX-101.INS 1392692
13 EX-101.SCH idra-20190930.xsd EX-101.SCH 45921
14 EX-101.CAL idra-20190930_cal.xml EX-101.CAL 40568
15 EX-101.DEF idra-20190930_def.xml EX-101.DEF 168331
16 EX-101.LAB idra-20190930_lab.xml EX-101.LAB 367067
17 EX-101.PRE idra-20190930_pre.xml EX-101.PRE 304762
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 191196289
SIC: 2836 Biological Products, (No Diagnostic Substances)